1. Yes. As described in the announcement no other adverse effects were observed.
2. The mice did not lose their fur. Having said this, this was not a model of alopecia.
3. It is progressing, but given the aim is to publish this work in one of the highest impact journals a great deal of work has to be done especially around the mechanism of action. While journal articles are nice to have, they are less important than progressing RC220.
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage, page-113
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |